SHLTN — SHL Telemedicine Balance Sheet
0.000.00%
- CH₣39.65m
- CH₣32.55m
- $58.69m
Annual balance sheet for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 27.2 | 15 | 22.1 | 11.7 | 25.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.32 | 8.38 | 9.12 | 7.35 | 8.76 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 45.9 | 32.3 | 40.1 | 27.5 | 36.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17 | 15.7 | 12.1 | 10.8 | 8.59 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 130 | 111 | 113 | 80.8 | 84.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.4 | 17.8 | 17.4 | 26.5 | 29 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 72.7 | 55.1 | 39.5 | 41.5 | 40.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 56.9 | 55.7 | 73.5 | 39.2 | 43.8 |
| Total Liabilities & Shareholders' Equity | 130 | 111 | 113 | 80.8 | 84.6 |
| Total Common Shares Outstanding |